3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
2
Myeloproliferative Disorders
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
von Hippel-Lindau Disease
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pyruvate Kinase Deficiency of Red Cells
1
Neuroendocrine Tumors
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Metastatic Castration-resistant Prostate Cancer
1
Marijuana Abuse
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphedema
1
Locally Advanced Head and Neck Carcinoma
1
Liver Neoplasms
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Biopsy
7
pembrolizumab
6
Doxorubicin
6
Cyclophosphamide
6
X-Rays
4
Radiation
4
Phantoms, Imaging
4
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Irinotecan
3
Ifosfamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pazopanib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
ensartinib
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Blood Specimen Collection
×
30 days
×
Clear all
No trials found.